{"id":"azzalure-or-dysport","safety":{"commonSideEffects":[{"rate":"5–15","effect":"Headache"},{"rate":"10–20","effect":"Injection site pain or bruising"},{"rate":"1–3","effect":"Eyelid ptosis"},{"rate":"1–2","effect":"Brow ptosis"},{"rate":"1–5","effect":"Facial asymmetry"}]},"_chembl":{"chemblId":"CHEMBL5970128","moleculeType":null,"molecularWeight":"607.73"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Botulinum toxin type A binds to SNARE proteins on presynaptic nerve terminals and cleaves them, preventing the release of acetylcholine. This leads to temporary paralysis of targeted facial muscles, smoothing dynamic wrinkles and expression lines. The effect is reversible and typically lasts 3–4 months.","oneSentence":"Azzalure is a botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction, paralyzing facial muscles and reducing wrinkles.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:29.434Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe glabellar lines (frown lines between eyebrows)"},{"name":"Moderate to severe lateral canthal lines (crow's feet)"},{"name":"Forehead lines"}]},"trialDetails":[{"nctId":"NCT06807164","phase":"PHASE2","title":"Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome","status":"RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2026-03-31","conditions":"Post-Mastectomy Neuropathic Pain Syndrome","enrollment":123},{"nctId":"NCT07489430","phase":"PHASE2","title":"DaxibotulinumtoxinA for Blepharospasm","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-07-01","conditions":"Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid, Blepharospasm of Right Eyelid","enrollment":20},{"nctId":"NCT07398755","phase":"","title":"Prospective, Non-interventional Study Assessing Periorbital Rejuvenation Procedure","status":"COMPLETED","sponsor":"Yuvell","startDate":"2025-09-02","conditions":"Glabellar Lines, Midface Volume Deficiency, Periorbital Wrinkling","enrollment":29},{"nctId":"NCT03992404","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merz Pharmaceuticals GmbH","startDate":"2019-09-16","conditions":"Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury","enrollment":603},{"nctId":"NCT07426640","phase":"NA","title":"Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation","status":"COMPLETED","sponsor":"Al Mouwasat Hospital","startDate":"2021-11-01","conditions":"Premature (Early) Ejaculation","enrollment":150},{"nctId":"NCT06721520","phase":"PHASE2, PHASE3","title":"Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-12-03","conditions":"Esophageal Cancer Surgery, Esophagectomy, Delayed Gastric Emptying Following Procedure","enrollment":170},{"nctId":"NCT07431944","phase":"NA","title":"Silencing Neuroma Pain-Botulinum Toxin Versus Local Anesthetic Injection","status":"NOT_YET_RECRUITING","sponsor":"Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)","startDate":"2026-02-15","conditions":"Pain Management, Pain, Phantom Limb Pain","enrollment":100},{"nctId":"NCT04752774","phase":"PHASE1, PHASE2","title":"A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.","status":"RECRUITING","sponsor":"Ipsen","startDate":"2021-04-29","conditions":"Spasticity","enrollment":240},{"nctId":"NCT07422441","phase":"NA","title":"Compliance-Guided Abdominal Wall Closure Strategy in Large Ventral Hernia Repair","status":"NOT_YET_RECRUITING","sponsor":"Swissmed Hospital","startDate":"2026-02-20","conditions":"Hernia, Ventral, Hernia Incisional, Postoperative Complications","enrollment":50},{"nctId":"NCT06438861","phase":"NA","title":"Role of Combination Therapy in Women With Refractory Overactive Bladder","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2025-01-01","conditions":"Overactive Bladder Syndrome","enrollment":""},{"nctId":"NCT07388927","phase":"PHASE4","title":"A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A","status":"NOT_YET_RECRUITING","sponsor":"DKSH Management (Thailand) Limited","startDate":"2026-02","conditions":"Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type A, Crow's Feet Lines, Lateral Canthal Lines, LCL","enrollment":48},{"nctId":"NCT05512039","phase":"PHASE1, PHASE2","title":"Reduced-dose Botox for Urgency Incontinence Among Elder Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2023-05-12","conditions":"Overactive Bladder, Urinary Incontinence in Old Age, Urgency Urinary Incontinence","enrollment":376},{"nctId":"NCT07377929","phase":"","title":"Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms","status":"RECRUITING","sponsor":"Benaroya Research Institute","startDate":"2026-01-19","conditions":"Benign Prostatic Hypertrophy (BPH), Lower Urinary Track Symptoms","enrollment":20},{"nctId":"NCT07374965","phase":"","title":"A Prospective, Non-Interventional, Single-Centre Study Assessing the Efficacy of a Holistic Upper Face Treatment With Botulinum Neurotoxin A","status":"COMPLETED","sponsor":"Yuvell","startDate":"2024-01-29","conditions":"Glabellar Lines, Forehead Lines, Crow's Feet","enrollment":20},{"nctId":"NCT07374341","phase":"NA","title":"The Effectiveness of Guided Botulinum Toxin \"A\" Injection to the Masticatory Muscles in the Management of Condylar and Subcondylar Fractures","status":"RECRUITING","sponsor":"Pakinam Gheeta","startDate":"2025-04-10","conditions":"Condylar Fractures, Subcondylar Fracture","enrollment":16},{"nctId":"NCT07360483","phase":"NA","title":"Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-01-01","conditions":"Hypertrophic Scars","enrollment":48},{"nctId":"NCT02414425","phase":"PHASE3","title":"Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-11-25","conditions":"Fecal Incontinence","enrollment":200},{"nctId":"NCT02816151","phase":"PHASE3","title":"Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's Doses","status":"COMPLETED","sponsor":"CHU de Reims","startDate":"2011-02","conditions":"Neurogenic Vesical Hyperactivity Syndrom","enrollment":29},{"nctId":"NCT05478551","phase":"PHASE2, PHASE3","title":"Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-01","conditions":"Scar, Hypertrophic Scar","enrollment":12},{"nctId":"NCT06899438","phase":"NA","title":"Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not","status":"COMPLETED","sponsor":"Bursa City Hospital","startDate":"2009-08-26","conditions":"Myofacial Pain Syndromes","enrollment":38},{"nctId":"NCT07295288","phase":"PHASE4","title":"Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-02-01","conditions":"Synkinesis","enrollment":50},{"nctId":"NCT05534399","phase":"NA","title":"Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-05","conditions":"Urinary Tract Disease","enrollment":526},{"nctId":"NCT07303582","phase":"PHASE4","title":"Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities","status":"RECRUITING","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2025-12-02","conditions":"Centreal Neurological Condition, Acquired Brain Injury (Including Stroke), Multiple Sclerosis","enrollment":50},{"nctId":"NCT07057050","phase":"NA","title":"Constraint-induced Movement Therapy Versus Task-oriented Training On Upper Extremity Function Post-Botox Injection in Stroke Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-06-30","conditions":"Constraint Induced Movement Therapy, Task Oriented Training, Botox Injection","enrollment":51},{"nctId":"NCT06387394","phase":"PHASE3","title":"A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence","status":"COMPLETED","sponsor":"AbbVie","startDate":"2024-04-22","conditions":"Masseter Muscle Prominence","enrollment":202},{"nctId":"NCT03935295","phase":"PHASE4","title":"Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2020-09-03","conditions":"Adolescent Idiopathic Scoliosis","enrollment":90},{"nctId":"NCT07270042","phase":"NA","title":"Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection","status":"NOT_YET_RECRUITING","sponsor":"Tishreen University","startDate":"2025-12-01","conditions":"Hyperactive Masseter Muscle","enrollment":20},{"nctId":"NCT07220382","phase":"PHASE4","title":"Preoperative BOTOX® Injection for Large Ventral Hernia Repair","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-11-03","conditions":"Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral","enrollment":188},{"nctId":"NCT06399718","phase":"PHASE3","title":"A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2024-04-30","conditions":"Masseter Muscle Prominence","enrollment":207},{"nctId":"NCT05123053","phase":"PHASE2","title":"Firdapse for Post-BOTOX Vocal Weakness","status":"COMPLETED","sponsor":"Augusta University","startDate":"2021-10-28","conditions":"Vocal Weakness(Post-BOTOX Injection)","enrollment":18},{"nctId":"NCT05806164","phase":"PHASE4","title":"Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-06-06","conditions":"Urgency Urinary Incontinence","enrollment":432},{"nctId":"NCT07184307","phase":"NA","title":"Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial","status":"RECRUITING","sponsor":"Benha University","startDate":"2025-04-15","conditions":"Overactive Bladder Syndrome, Urinary Urge Incontinence, Detrusor Overactivity","enrollment":48},{"nctId":"NCT07180394","phase":"NA","title":"Botulinum Toxin for Strabismus Treatment","status":"NOT_YET_RECRUITING","sponsor":"Foundation University Islamabad","startDate":"2025-09-30","conditions":"Strabismic Deviation, Strabismus","enrollment":127},{"nctId":"NCT05403710","phase":"","title":"Botulinum Toxin Therapy in Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"University of Massachusetts, Worcester","startDate":"2022-06-07","conditions":"Hidradenitis Suppurativa, Hyperhidrosis","enrollment":20},{"nctId":"NCT05430893","phase":"","title":"Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-01","conditions":"Athletic Pubalgia","enrollment":20},{"nctId":"NCT06246552","phase":"PHASE2","title":"Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines","status":"COMPLETED","sponsor":"Jetema USA Inc.","startDate":"2024-10-26","conditions":"Glabellar Lines","enrollment":480},{"nctId":"NCT06137287","phase":"PHASE3","title":"A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2023-11-22","conditions":"Masseter Muscle Prominence","enrollment":259},{"nctId":"NCT06796985","phase":"PHASE1","title":"Botox for Chronic Pelvic Pain","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-02-24","conditions":"Pelvic Floor Disorders","enrollment":30},{"nctId":"NCT06091020","phase":"PHASE2","title":"A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury","status":"COMPLETED","sponsor":"Merz Therapeutics GmbH","startDate":"2023-11-22","conditions":"Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury","enrollment":123},{"nctId":"NCT05874154","phase":"NA","title":"Evaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-01-02","conditions":"Post Stroke Seizure, Spastic Foot","enrollment":60},{"nctId":"NCT07040813","phase":"PHASE3","title":"The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2025-06-06","conditions":"Migraine, Chronic Migraine Headache","enrollment":450},{"nctId":"NCT04609020","phase":"PHASE4","title":"Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment","status":"COMPLETED","sponsor":"Allergan","startDate":"2023-02-15","conditions":"Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality","enrollment":64},{"nctId":"NCT07013240","phase":"PHASE3","title":"Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2025-07-05","conditions":"Sternotomy Closure,Open Heart Surgery","enrollment":50},{"nctId":"NCT04171531","phase":"PHASE3","title":"Sling vs Botox for Mixed Incontinence","status":"COMPLETED","sponsor":"NICHD Pelvic Floor Disorders Network","startDate":"2020-06-08","conditions":"Urinary Incontinence, Stress, Urinary Incontinence, Urge","enrollment":150},{"nctId":"NCT03654066","phase":"PHASE4","title":"Botox or Botox With Esophageal Dilation in Patients With Achalasia","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2019-05-13","conditions":"Achalasia","enrollment":50},{"nctId":"NCT06059066","phase":"NA","title":"Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction","status":"COMPLETED","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-10-04","conditions":"Neurogenic Bladder, Lower Urinary Tract Symptoms, Overactive Bladder","enrollment":78},{"nctId":"NCT06956729","phase":"NA","title":"Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)","status":"RECRUITING","sponsor":"Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús","startDate":"2024-10-01","conditions":"Cerebral Palsy","enrollment":42},{"nctId":"NCT06195241","phase":"PHASE4","title":"Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2025-02-11","conditions":"Benign Essential Blepharospasm, Hemifacial Spasm","enrollment":40},{"nctId":"NCT05367271","phase":"PHASE2, PHASE3","title":"The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis","status":"COMPLETED","sponsor":"Western Institute for Veterans Research","startDate":"2022-08-23","conditions":"Plantar Fasciitis","enrollment":62},{"nctId":"NCT06886750","phase":"PHASE4","title":"The Effects of Waning of Botulinum Toxin in the Treatment of Cervical Dystonia","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2025-03-30","conditions":"Cervical Dystonia, Primary","enrollment":45},{"nctId":"NCT04763265","phase":"PHASE2","title":"Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2020-06-24","conditions":"Frown Lines","enrollment":208},{"nctId":"NCT06865794","phase":"","title":"Impact of Plastic and Aesthetic Surgery on Self-esteem","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-04-15","conditions":"Self Esteem","enrollment":1500},{"nctId":"NCT06814535","phase":"PHASE2, PHASE3","title":"A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-06-01","conditions":"Patients with Jaw Muscles Myofascial Pain","enrollment":60},{"nctId":"NCT06296082","phase":"PHASE2, PHASE3","title":"Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2024-09-01","conditions":"Stroke","enrollment":90},{"nctId":"NCT02969356","phase":"PHASE4","title":"Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)","status":"COMPLETED","sponsor":"Ipsen","startDate":"2016-12-18","conditions":"Spastic Hemiparesis","enrollment":157},{"nctId":"NCT06811142","phase":"EARLY_PHASE1","title":"Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-01-28","conditions":"Spasticity, Stroke, Neurological Rehabilitation","enrollment":200},{"nctId":"NCT06336785","phase":"PHASE4","title":"Kiss and Smile HIT (Holistic Individualized Treatment)","status":"COMPLETED","sponsor":"Erevna Innovations Inc.","startDate":"2023-11-02","conditions":"Aesthetic","enrollment":24},{"nctId":"NCT06804993","phase":"PHASE4","title":"Rectocele Repair with or Without Internal Sphincter Botulinum Toxin Injection: a Prospective Randomized Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2021-07-31","conditions":"Obstructed Defaecation Syndrome, Anterior Rectocele","enrollment":60},{"nctId":"NCT02216838","phase":"PHASE4","title":"Treatment of Facial Flushing With Botulinum Toxin A Injections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2014-08","conditions":"Facial Flushing","enrollment":16},{"nctId":"NCT05328687","phase":"","title":"Examination of Muscle Stiffness, Tenderness and Pressure Pain Thresholds During a Cycle of Botulinum Toxin A Treatment in Chronic Migraine Patients","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2021-05-01","conditions":"Chronic Migraine","enrollment":60},{"nctId":"NCT05605756","phase":"PHASE4","title":"BOTOX Effects on Seizure Severity and Susceptibility","status":"TERMINATED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2023-03-01","conditions":"Drug-resistant Focal Seizure","enrollment":3},{"nctId":"NCT05872932","phase":"PHASE2, PHASE3","title":"Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment","status":"COMPLETED","sponsor":"Sebahattin Celik MD","startDate":"2023-12-30","conditions":"Obesity","enrollment":131},{"nctId":"NCT06499324","phase":"PHASE3","title":"Surgery with Botulinum Toxin a for Incisional Hernia","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-01-17","conditions":"Incisional Hernia","enrollment":260},{"nctId":"NCT05158634","phase":"","title":"Relationship of Trunk Control and Endurance with Balance and Functional Mobility in Cerebral Palsy","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2021-12-30","conditions":"Cerebral Palsy","enrollment":32},{"nctId":"NCT06755099","phase":"PHASE2, PHASE3","title":"Female Sexual Dysfunction Assessment and Managment of Vaginismus","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-01-01","conditions":"Female Sexual Dysfunction","enrollment":40},{"nctId":"NCT06742658","phase":"","title":"Rapid Move Following Outpatient Surgery: Safety and Patient Characteristics","status":"NOT_YET_RECRUITING","sponsor":"Algemeen Ziekenhuis Maria Middelares","startDate":"2025-12","conditions":"Postoperative Recovery","enrollment":1500},{"nctId":"NCT04975646","phase":"NA","title":"Goal Attainment Scaling in Upper Limb Spasticity Treatment","status":"RECRUITING","sponsor":"University Rehabilitation Institute, Republic of Slovenia","startDate":"2021-01-03","conditions":"Ischemic Stroke, Hemorrhagic Stroke","enrollment":70},{"nctId":"NCT04630873","phase":"PHASE1","title":"Low or High Botox Dilution for the Hemiplegic Gait?","status":"RECRUITING","sponsor":"University of Ioannina","startDate":"2020-11-20","conditions":"Post Stroke Spastic Hemiplegia","enrollment":20},{"nctId":"NCT06583590","phase":"PHASE2, PHASE3","title":"Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction","status":"RECRUITING","sponsor":"Aswan University Hospital","startDate":"2024-08-01","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":32},{"nctId":"NCT05072821","phase":"PHASE4","title":"Botulinum Toxin Type a Injection to Prevent Keloid Recurrence","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-10-13","conditions":"Scar Keloid","enrollment":28},{"nctId":"NCT05698979","phase":"PHASE3","title":"Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-01-01","conditions":"Buerger Disease, Raynaud Syndrome","enrollment":8},{"nctId":"NCT06543979","phase":"PHASE1, PHASE2","title":"Anorectal Manometery in Pediatric Chronic Refractory Constipation","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-09-07","conditions":"Chronic Constipation","enrollment":60},{"nctId":"NCT04916444","phase":"NA","title":"Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-02-07","conditions":"Cervical Dystonia","enrollment":5},{"nctId":"NCT05647551","phase":"PHASE4","title":"A Study to Evaluate Satisfaction in Adult Participants With the Aesthetics of the Periorbital Area After JUVÉDERM® Fillers and BOTOX®/VISTABEL® Injections","status":"COMPLETED","sponsor":"AbbVie","startDate":"2023-01-05","conditions":"Facial Corrections, Facial Lines","enrollment":73},{"nctId":"NCT04819360","phase":"PHASE4","title":"Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple Sclerosis","status":"TERMINATED","sponsor":"Brigitte Schürch","startDate":"2021-06-01","conditions":"Urinary Bladder, Neurogenic, Multiple Sclerosis","enrollment":1},{"nctId":"NCT06537700","phase":"","title":"OnaBotulinumtoxin-A in Chronic Migraine Patients with Short or Long Disease History (the BACH Study)","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2024-01-01","conditions":"Migraine","enrollment":115},{"nctId":"NCT05884528","phase":"","title":"Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia","status":"COMPLETED","sponsor":"Merz Therapeutics GmbH","startDate":"2023-07-08","conditions":"Cervical Dystonia","enrollment":270},{"nctId":"NCT01177358","phase":"PHASE2","title":"Botox in the Healing of Surgical Wounds of the Neck","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2010-05-31","conditions":"Scar","enrollment":40},{"nctId":"NCT05426161","phase":"PHASE4","title":"The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2023-02-07","conditions":"Chronic Pain, Lower Extremity Wound","enrollment":10},{"nctId":"NCT05284019","phase":"PHASE4","title":"Real World Effectiveness of Eptinezumab in Participants With Migraine","status":"TERMINATED","sponsor":"H. Lundbeck A/S","startDate":"2022-03-04","conditions":"Migraine","enrollment":32},{"nctId":"NCT04589364","phase":"PHASE3","title":"Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients","status":"NOT_YET_RECRUITING","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2024-05-01","conditions":"Hemifacial Spasm","enrollment":120},{"nctId":"NCT04124939","phase":"PHASE4","title":"Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-11-10","conditions":"Overactive Bladder","enrollment":41},{"nctId":"NCT06354127","phase":"PHASE3","title":"DWP450 for Treating Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2020-08-12","conditions":"Moderate to Severe Glabellar Lines","enrollment":473},{"nctId":"NCT03814889","phase":"NA","title":"Passive Tactile Stimulation for Stroke Rehabilitation","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-05-15","conditions":"Stroke, Stroke, Ischemic, Stroke Hemorrhagic","enrollment":35},{"nctId":"NCT06328556","phase":"NA","title":"Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Copka Sonpashan","startDate":"2024-03","conditions":"Cricopharyngeal Achalasia","enrollment":30},{"nctId":"NCT05807412","phase":"EARLY_PHASE1","title":"Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides","status":"COMPLETED","sponsor":"Lupo Center for Aesthetic and General Dermatology","startDate":"2023-05-01","conditions":"Rhytides","enrollment":10},{"nctId":"NCT06225024","phase":"NA","title":"Efficacy of Extracorporeal Shock Wave Therapy on Spasticity","status":"COMPLETED","sponsor":"Kayseri City Hospital","startDate":"2022-03-15","conditions":"Stroke, Spasticity, Muscle","enrollment":40},{"nctId":"NCT04349176","phase":"PHASE3","title":"Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?","status":"TERMINATED","sponsor":"United States Naval Medical Center, San Diego","startDate":"2017-05-12","conditions":"Chronic Migraine, Headache","enrollment":35},{"nctId":"NCT06230146","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-05-01","conditions":"Keloid","enrollment":45},{"nctId":"NCT06209333","phase":"NA","title":"Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS","status":"UNKNOWN","sponsor":"Hacettepe University","startDate":"2023-10-15","conditions":"Overactive Bladder Syndrome (OABS)","enrollment":50},{"nctId":"NCT03480724","phase":"NA","title":"Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2017-07-06","conditions":"Pain","enrollment":55},{"nctId":"NCT05719285","phase":"PHASE4","title":"Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2022-12-06","conditions":"Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence","enrollment":100},{"nctId":"NCT06128616","phase":"PHASE3","title":"Efficacy of Extracorporeal Shock Wave Therapy in Children With Cerebral Palsy","status":"UNKNOWN","sponsor":"Kocaeli University","startDate":"2023-11","conditions":"Spasticity/Paresis, Cerebral Palsy","enrollment":40},{"nctId":"NCT04817865","phase":"","title":"Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection","status":"WITHDRAWN","sponsor":"Pathnostics","startDate":"2020-08-15","conditions":"Urinary Tract Infections","enrollment":""},{"nctId":"NCT03712449","phase":"PHASE4","title":"A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment","status":"COMPLETED","sponsor":"Allergan","startDate":"2019-01-22","conditions":"Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality","enrollment":59},{"nctId":"NCT04922983","phase":"PHASE2","title":"Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis","status":"UNKNOWN","sponsor":"Manhattan Physical Medicine and Rehabilitation, LLP","startDate":"2021-07-01","conditions":"Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis; Lumbar Region","enrollment":42},{"nctId":"NCT06044883","phase":"PHASE1, PHASE2","title":"Radiological Evaluation of the Penis Before and After a Botox Injection","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-01","conditions":"Erectile Dysfunction","enrollment":32},{"nctId":"NCT03821402","phase":"PHASE2","title":"Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-12-12","conditions":"Upper Limb Spasticity","enrollment":83},{"nctId":"NCT04826900","phase":"NA","title":"Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-08-01","conditions":"Hemiplegia, Spastic, Spastic","enrollment":31},{"nctId":"NCT06036043","phase":"","title":"Botulinum Toxin for Chronic Neuropathic Pain","status":"UNKNOWN","sponsor":"Region Zealand","startDate":"2023-08-01","conditions":"Neuralgia, Chronic Pain","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Botulinum toxin"],"phase":"marketed","status":"active","brandName":"Azzalure or Dysport","genericName":"Azzalure or Dysport","companyName":"Galderma R&D","companyId":"galderma-r-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azzalure is a botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction, paralyzing facial muscles and reducing wrinkles. Used for Moderate to severe glabellar lines (frown lines between eyebrows), Moderate to severe lateral canthal lines (crow's feet), Forehead lines.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}